Healthcare -
Biotechnology - NASDAQ - US
$ 7.9
0.381 %
$ 1.64 B
Market Cap
-12.95
P/E
BCRX - CASH & EQUIVALENTS
Cash & Equivalents BCRX - BioCryst Pharmaceuticals, Inc.
111 M
LAST VALUE
-53.16%
2 YEAR CAGR
32.86%
5 YEAR CAGR
17.99%
10 YEAR CAGR